Metastasis From Malignant Tumor of Prostate clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
open to eligible males ages 18 years and up
A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
at UCSF
Last updated: